Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter: Betsy Adegborioye, PharmD Candidate 2022, South College School of Pharmacy Janet Falade, PharmD Candidate, South College School of Pharmacy Milane Kenguim, PharmD Candidate, South College School of Pharmacy Aleksandra Kusic, PharmD Candidate, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences Amanda Roberts, PharmD Candidate, Florida A&M University, College of Pharmacy and Pharmaceutical Sciences Institute of Public Health Emily Walser, PharmD Candidate 2022, Lake Erie College of Osteopathic Medicine, College of Pharmacy | 
Over the past few years the use of CGMs has increased significantly. More and more providers, insurers and benefit managers have seen the value of their use. Where we only had individual readings and A1c to gauge overall management success, the use of CGMs has allowed “Time in Range” to become a measurement that is even more important in overall management. These devices have also made it possible for “smart pumps" to predict glucose trends and adjust insulin accordingly.